Table 5.

Novel, low-molecular weight, pharmacological immunostimulants which may augment immunogenic cell death.

Agent	Immunostimulatory Mechanism
CA-170	Targets PD-L1 and VISTA [124] *
LYC-55716	Agonist of RORγt [125]
Galunisertib	Antagonist of the tyrosine kinase domain of TGF-β receptor type 1 [126]
Indoximod	Prototype inhibitor of indoleamine-2,3-dioxygenase [123,127,128]
CB-1158	Granulocyte arginase inhibitor [129]
CPI-444 and AZD4635	Antagonists of the T cell A2a receptor [130,131,132]

* Denotes the relevant references as cited in the text.